Gyros AB Appoints Dr Henrik Björkman as CTO and VP Technical Affairs
News Jan 21, 2013
As part of his new role at Gyros, Henrik will have responsibility for driving strategic and operational decisions, managing product development, intellectual property, manufacturing, QA, and QC, and will oversee the existing product range. As part of the executive management team Henrik will work closely with marketing and sales departments, reporting to the board of directors.
Henrik joins Gyros from GE Healthcare Life Sciences, where he was most recently Director, MicroCal R&D, leading the MicroCal operation in Northampton, MA. He has many years of experience in senior positions within R&D, technical and management roles, at a range of life science companies from small organizations to larger, industrial enterprises. Henrik holds a PhD in Materials Science and Micro Engineering from Uppsala University.
“The technology developed at Gyros offers an exciting step forward for the biopharmaceutical community,” said Henrik. “I am excited to have the opportunity to support the continued success of the Gyros immunoassay platform.”
Erik Walldén, CEO at Gyros, commented: “We welcome Henrik to Gyros, and look forward to working with him. Bringing extensive experience in product development and manufacturing for globalized, commercial organizations in the life science tools industry, Henrik will be a great asset for the continued development of our microfluidic immunoassay technology.”
Researchers have developed an artificial enzymatic pathway for synthesizing isoprenoids, or terpenes, in E. coli. This shorter, more efficient, cost-effective and customizable pathway transforms E. coli into a factory that can produce terpenes for use in everything from cancer drugs to biofuels.READ MORE